1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Severe Psoriasis Global Clinical Trials Review, H2, 2014

Severe Psoriasis Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 116 pages

Severe Psoriasis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Severe Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Severe Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Severe Psoriasis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Severe Psoriasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Severe Psoriasis to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Severe Psoriasis to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Severe Psoriasis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Severe Psoriasis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AbbVie Inc. 34
Clinical Trial Overview of AbbVie Inc. 34
Johnson and Johnson 37
Clinical Trial Overview of Johnson and Johnson 37
Amgen Inc. 39
Clinical Trial Overview of Amgen Inc. 39
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Merck and Co., Inc. 43
Clinical Trial Overview of Merck and Co., Inc. 43
Novartis AG 45
Clinical Trial Overview of Novartis AG 45
E. Merck KG 46
Clinical Trial Overview of E. Merck KG 46
F. Hoffmann-La Roche Ltd. 48
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 48
Innovaderm Research Inc. 49
Clinical Trial Overview of Innovaderm Research Inc. 49
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Clinical Trial Overview of Top Institutes / Government 51
Rutgers, The State University of New Jersey 51
Clinical Trial Overview of Rutgers, The State University of New Jersey 51
Academic Medical Center 52
Clinical Trial Overview of Academic Medical Center 52
National Cancer Institute 53
Clinical Trial Overview of National Cancer Institute 53
University of California, San Francisco 54
Clinical Trial Overview of University of California, San Francisco 54
Tufts Medical Center 55
Clinical Trial Overview of Tufts Medical Center 55
Dresden University of Technology 56
Clinical Trial Overview of Dresden University of Technology 56
University Hospitals of Leicester NHS Trust 57
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 57
Erasmus MC 58
Clinical Trial Overview of Erasmus MC 58
Radboud University Nijmegen Medical Centre 59
Clinical Trial Overview of Radboud University Nijmegen Medical Centre 59
Rockefeller University 60
Clinical Trial Overview of Rockefeller University 60
Five Key Clinical Profiles 61
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Severe Psoriasis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Severe Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Severe Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Severe Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Severe Psoriasis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Severe Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Severe Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Severe Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Severe Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Severe Psoriasis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Severe Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Severe Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Severe Psoriasis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Severe Psoriasis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Severe Psoriasis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Severe Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Severe Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Severe Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Severe Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Severe Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 34
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 37
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 39
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 41
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 43
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 45
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 46
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 48
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014* 49
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 50
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014* 51
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 52
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 53
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 54
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2014* 55
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014* 56
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 57
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 58
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2014* 59
Severe Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockefeller University, 2014* 60

List of Figures

Severe Psoriasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Severe Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Severe Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Severe Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Severe Psoriasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Severe Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Severe Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Severe Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Severe Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Severe Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Severe Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Severe Psoriasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Severe Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Severe Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Severe Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Severe Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Severe Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Severe Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Severe Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Severe Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 115

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.